Synergy Pharmaceuticals (NASDAQ: SGYP) has recently received a number of price target changes and ratings updates: 3/5/2018 – Synergy Pharmaceuticals was given a new $7.00 price target on by analysts at HC Wainwright. They now have a “buy” rating on the stock. 3/1/2018 – Synergy Pharmaceuticals had its “hold” rating reaffirmed by analysts at Oppenheimer […]